Cell-Free DNA Isolation and Extraction Market - 1-3 USERS:2022

Market Report Coverage :
Start Year : 2021 - Forecast Year : 2031 - Start Value : $195.0 Million in 2021 - Forecast Value : $735.1 Million by 2031 - CAGR % : 0.14%
Description :
Market Report Coverage - Cell-Free DNA Isolation and ExtractionMarket Segmentation• Consumable - Cell-Free DNA Isolation and Extraction Kits, ell-Free DNA Isolation and Extraction Tubes, and Other Consumables• Platform - Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms• Technique - Magnetic Beads-Based, Spin Column-Based, and Other Techniques• Application - Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications• End-User - Academic Research Institutes and Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Clinical Diagnostic Centers, and Other End UsersRegional Segmentation• North America - U.S., Canada• Europe - Germany, U.K., France, Italy, Spain, Denmark, and Rest-of-Europe• Asia-Pacific - China, India, Japan, Singapore, South Korea, Australia, and Rest-of-Asia-Pacific• Rest-of-the-WorldMarket Growth Drivers• Cell-Free DNA Isolation and Extraction Inclined by Rising Prevalence of Cancer• Strategic Initiatives by Key Market Players• Rise in the Field of Microbial SequencingMarket Challenges• High Cost of Automated Instruments• Genomic Data Protection• Rigid Regulatory StandardsMarket Opportunities• Technological Advancement Toward Innovation in Cell-Free DNA Isolation and Extraction• Massive Scope for Adoption of NGS-based Genetic Tests in Emerging MarketsKey Companies ProfiledThermo Fisher Scientific Inc., QIAGEN, Danaher, PerkinElmer, Inc., Endress+Hauser AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Illumina, Inc., Takara Bio Inc., Aline Biosciences, EpiGentek Group, Inc., Omega Bio-tek, Inc., Promega Corporation, Streck, Inc., AccuBioMed Co., Ltd., AMSBIO, Covaris, Inc., EntroGen, Inc., NeoGeneStar LLC, Norgen Biotek Corp., STRATEC SE, System Biosciences, LLC, Vela DiagnosticsKey Questions Answered in this Report:• How is cell-free DNA isolation and extraction revolutionizing oncology?• What are the major market drivers, challenges, and opportunities in the global cell-free DNA isolation and extraction market?• What are the underlying structures resulting in the emerging trends within the global cell-free DNA isolation and extraction market?• How is the COVID-19 pandemic impacting the global cell-free DNA isolation and extraction ecosystem?• What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?• What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction-targeted therapies?• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? • How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments: o Consumable (Cell-Free DNA Isolation and Extraction Kits, Cell-Free DNA Isolation and Extraction Tubes, and Other Consumables) o Platform (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms) o Technique (Magnetic Beads-Based, Spin Column-Based, and Other Techniques) o Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications) o End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and Other End Users) o Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)• What are the growth opportunities for the cell-free DNA isolation and extraction companies in the region of their operation?• Who are the leading players with significant offerings in the global cell-free DNA isolation and extraction market? • Which companies are anticipated to be highly disruptive in the future, and why?Market OverviewThe use of cell-free DNA isolation and extraction kits, tubes, and other consumables has increased due to the rising prevalence of cancer, the increasing key player initiatives, and the rising government initiatives in the cell-free DNA isolation and extraction market. The constant significant investments by healthcare companies to meet industry demand and the growing adoption of cell-free DNA isolation and extraction kits, tubes, and reagents among major end users are the major factors propelling the growth of the global cell-free DNA isolation and extraction market. The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.Competitive LandscapeThe global cell-free DNA isolation and extraction market comprise well-established and newly emerging companies. Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for the isolation and extraction of cell-free DNA from different sample types. Key market players of the global cell-free DNA isolation and extraction market witnessed product launch, product approval and business funding, and synergistic activities majorly during the period January 2018-November 2021. The inclination of companies toward product launches suggests that the companies are involved in continuously bringing new products to the market to isolate cell-free DNA, which is primarily attributed to an increase in liquid biopsy studies and approval of several liquid biopsy assays by the regulatory agencies.
Countries Covered :
North America U.S. CanadaEurope Germany Italy France U.K. Spain Denmark Rest-of-EuropeAsia-Pacific China India Singapore Japan Australia South Korea Rest-of-Asia-PacificLatin America Brazil Mexico Rest-of-Latin America (RoLA)Rest-of-the-World
Keywords :
Cell-Free DNA Isolation and Extraction Market, Cell-Free DNA Isolation and Extraction Industry, Cell-Free DNA Isolation and Extraction Report, Cell-Free DNA Isolation Market, Cell-Free DNA Isolation Industry, Cell-Free DNA Isolation Report, Cell-Free DNA Extraction Market, Cell-Free DNA Extraction Industry, Cell-Free DNA Extraction Report, Cell-Free DNA Isolation and Extraction Market Forecasts, Cell-Free DNA Isolation and Extraction Market Trends, Cell-Free DNA Isolation and Extraction Market Companies, Cell-Free DNA Isolation and Extraction Market Analysis, Cell-Free DNA Isolation and Extraction Industry Analysis, What are Cell-Free DNA Isolation and Extraction, Cell-Free DNA Isolation and Extraction Definition, Cell-Free DNA Isolation and Extraction Market Competitive Landscape, Cell-Free DNA Isolation and Extraction Market Drivers, Cell-Free DNA Isolation and Extraction Market Segments, Cell-Free DNA Isolation and Extraction Market Outlook, Cell-Free DNA Isolation and Extraction Market Opportunity, Cell-Free DNA Isolation and Extraction Market Growth, Cell-Free DNA Isolation and Extraction Market Share, Cell-Free DNA Isolation and Extraction Market Size, Cell-Free DNA Isolation and Extraction Market by Application, Cell-Free DNA Isolation and Extraction Market by Product, Cell-Free DNA Isolation and Extraction Market by Region, Cell-Free DNA Isolation and Extraction Market by Patent Applications, North America Cell-Free DNA Isolation and Extraction Market, Europe Cell-Free DNA Isolation and Extraction Market, Asia-Pacific Cell-Free DNA Isolation and Extraction Market, Latin America Cell-Free DNA Isolation and Extraction Market
Press Release :
The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is projected to reach $735.1 million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 14.19% during the forecast period 2021-2031.In the comprehensive study of the global cell-free DNA isolation and extraction market, BIS Research extensively covers the following:• Market numbers on micro-segments influencing the market• Market share analysis of key market players• Growth share analysis of companies• Impact of COVID-19 on the global cell-free DNA isolation and extraction market• Growth analysis by consumables, technology, techniques, application, end-user, and region • Detailed company and product profiling for 15 companies and snapshot for ten companiesBesides these parameters, the study also encompasses the market growth drivers, market restraining factors, opportunities, competition mapping, and segmental analysis.BIS Research study indicates that the growing prevalence of cancer, strategic initiatives by key market players, and rise in microbial sequencing are the major factors anticipated to contribute to the growth of the global cell-free DNA isolation and extraction market.BIS Research study highlights the following in the report:• Emerging opportunities in cell-free DNA isolation and extraction market• Impact of COVID-19 on the global cell-free DNA isolation and extraction market• Market scenario for cell-free DNA isolation and extraction kits, tubes, and consumables• Drivers promoting the growth of the marketData from different segments of the market has been analyzed minutely to gain a holistic view of the market. These segments include market segmented based on consumables, platform, techniques, application, end-user, and region. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.Key insights are drawn from in-depth interviews with the key opinion leaders of 25 leading companies, market participants, and vendors. Key players operating in the global cell-free DNA isolation and extraction market include Thermo Fisher Scientific Inc., QIAGEN, Danaher, PerkinElmer, Inc., Endress+Hauser AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Illumina, Inc., Takara Bio Inc., Aline Biosciences, EpiGentek Group, Inc., Omega Bio-tek, Inc., Promega Corporation, Streck, Inc., AccuBioMed Co., Ltd., AMSBIO, Covaris, Inc., EntroGen, Inc., NeoGeneStar LLC, Norgen Biotek Corp., STRATEC SE, System Biosciences, LLC, and Vela DiagnosticsWho should buy this report?• Manufacturers of cell-free DNA isolation and extraction kits, tubes, and other consumables• Pharmaceutical and biotechnology companies• Research and academic institutionsInsightful Questions Covered to Enable Companies Take Strategic Decisions• How is cell-free DNA isolation and extraction revolutionizing oncology?• What are the major market drivers, challenges, and opportunities in the global cell-free DNA isolation and extraction market?• What are the underlying structures resulting in the emerging trends within the global cell-free DNA isolation and extraction market?• How is the COVID-19 pandemic impacting the global cell-free DNA isolation and extraction ecosystem?• What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?• What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction-targeted therapies?• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? • How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments: o Consumable (Cell-Free DNA Isolation and Extraction Kits, Cell-Free DNA Isolation and Extraction Tubes, and Other Consumables) o Platform (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms) o Technique (Magnetic Beads-Based, Spin Column-Based, and Other Techniques) o Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications) o End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and Other End Users) o Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)• What are the growth opportunities for the cell-free DNA isolation and extraction companies in the region of their operation?• Who are the leading players with significant offerings in the global cell-free DNA isolation and extraction market? • Which companies are anticipated to be highly disruptive in the future, and why?
Companies Mentioned :
Thermo Fisher Scientific Inc.QIAGENDanaherPerkinElmer, Inc.Endress+Hauser AGAgilent Technologies, Inc.F. Hoffmann-La Roche Ltd.Merck KGaAIllumina, Inc.Takara Bio Inc.Aline BiosciencesEpiGentek Group, Inc.Omega Bio-tek, Inc.Promega CorporationStreck, Inc.AccuBioMed Co., Ltd.AMSBIOCovaris, Inc.EntroGen, Inc.NeoGeneStar LLCNorgen Biotek Corp.STRATEC SESystem Biosciences, LLCVela Diagnostics
Press Release :
The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is projected to reach $735.1 million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 14.19% during the forecast period 2021-2031.In the comprehensive study of the global cell-free DNA isolation and extraction market, BIS Research extensively covers the following:• Market numbers on micro-segments influencing the market• Market share analysis of key market players• Growth share analysis of companies• Impact of COVID-19 on the global cell-free DNA isolation and extraction market• Growth analysis by consumables, technology, techniques, application, end-user, and region • Detailed company and product profiling for 15 companies and snapshot for ten companiesBesides these parameters, the study also encompasses the market growth drivers, market restraining factors, opportunities, competition mapping, and segmental analysis.BIS Research study indicates that the growing prevalence of cancer, strategic initiatives by key market players, and rise in microbial sequencing are the major factors anticipated to contribute to the growth of the global cell-free DNA isolation and extraction market.BIS Research study highlights the following in the report:• Emerging opportunities in cell-free DNA isolation and extraction market• Impact of COVID-19 on the global cell-free DNA isolation and extraction market• Market scenario for cell-free DNA isolation and extraction kits, tubes, and consumables• Drivers promoting the growth of the marketData from different segments of the market has been analyzed minutely to gain a holistic view of the market. These segments include market segmented based on consumables, platform, techniques, application, end-user, and region. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.Key insights are drawn from in-depth interviews with the key opinion leaders of 25 leading companies, market participants, and vendors. Key players operating in the global cell-free DNA isolation and extraction market include Thermo Fisher Scientific Inc., QIAGEN, Danaher, PerkinElmer, Inc., Endress+Hauser AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Illumina, Inc., Takara Bio Inc., Aline Biosciences, EpiGentek Group, Inc., Omega Bio-tek, Inc., Promega Corporation, Streck, Inc., AccuBioMed Co., Ltd., AMSBIO, Covaris, Inc., EntroGen, Inc., NeoGeneStar LLC, Norgen Biotek Corp., STRATEC SE, System Biosciences, LLC, and Vela DiagnosticsWho should buy this report?• Manufacturers of cell-free DNA isolation and extraction kits, tubes, and other consumables• Pharmaceutical and biotechnology companies• Research and academic institutionsInsightful Questions Covered to Enable Companies Take Strategic Decisions• How is cell-free DNA isolation and extraction revolutionizing oncology?• What are the major market drivers, challenges, and opportunities in the global cell-free DNA isolation and extraction market?• What are the underlying structures resulting in the emerging trends within the global cell-free DNA isolation and extraction market?• How is the COVID-19 pandemic impacting the global cell-free DNA isolation and extraction ecosystem?• What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?• What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction-targeted therapies?• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region? • How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments: o Consumable (Cell-Free DNA Isolation and Extraction Kits, Cell-Free DNA Isolation and Extraction Tubes, and Other Consumables) o Platform (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms) o Technique (Magnetic Beads-Based, Spin Column-Based, and Other Techniques) o Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications) o End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and Other End Users) o Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)• What are the growth opportunities for the cell-free DNA isolation and extraction companies in the region of their operation?• Who are the leading players with significant offerings in the global cell-free DNA isolation and extraction market? • Which companies are anticipated to be highly disruptive in the future, and why?
Headline :
Global Cell-Free DNA Isolation and Extraction Market to Reach $735.1 Million by 2031
Table of Contents :
1 Global Cell-Free DNA Isolation and Extraction Market1.1 Product Definition1.1.1 Inclusion and Exclusion1.2 Market Scope1.2.1 Scope of the Study1.2.2 Key Questions Answered in the Report1.3 Market Overview1.3.1 Market Definition1.3.2 Early Discovery and Application of cfDNA1.3.3 Properties of cfDNA1.3.4 Biological Role of cfDNA1.3.5 Extraction of Circulating cfDNA1.3.6 Application of Circulating cfDNA1.3.7 Market Footprint and Growth Potential1.3.8 Disruption in Global Cell-Free DNA Isolation and Extraction Market Due to COVID-191.3.9 COVID-19 Affecting Supply Chain of Global Cell-Free DNA Isolation and Extraction Market1.3.10 Interruption in Research and Clinical Development and Commercial Operation1.3.10.1 Research and Clinical Development1.3.10.2 Commercial Operation1.3.11 Navigating Crisis Recovery and Looking to the Future2 Global Cell-Free DNA Isolation and Extraction Market: Industry Analysis2.1 Overview2.2 Legal Requirements and Framework in the U.S.2.2.1 FDA Regulation2.3 Legal Requirements and Framework in Europe2.4 Legal Requirements and Framework in Asia-Pacific2.4.1 China2.4.2 Japan3 Market Dynamics3.1 Overview3.2 Impact Analysis3.3 Market Drivers3.3.1 Cell-Free DNA Isolation and Extraction Inclined by Rising Prevalence of Cancer3.3.2 Strategic Initiatives by Key Market Players3.3.3 Rise in the Field of Microbial Sequencing3.4 Market Restraints3.4.1 High Cost of Automated Instruments3.4.2 Genomic Data Protection3.4.3 Rigid Regulatory Standards3.5 Market Opportunities3.5.1 Technological Advancement Toward Innovation in Cell-Free DNA Isolation and Extraction3.5.2 Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets4 Competitive Landscape4.1 Overview4.2 Product Launch and Upgradations4.3 Product Approvals and Business Funding4.4 Synergistic Activities4.5 Mergers and Acquisitions4.6 Market Share Analysis (by Company), 2019 and 20204.7 Growth Share Analysis (by Company)5 Consumables, $Million, 2020-20315.1 Overview5.2 Cell-Free DNA Isolation and Extraction Kits5.3 Cell-Free DNA Isolation and Extraction Tubes5.4 Other Consumables6 Platform6.1 Overview6.2 Next-Generation Sequencing (NGS)6.3 Polymerase Chain Reaction (PCR)6.3.1 Real-Time Polymerase Chain Reaction (RT-PCR)6.3.2 Digital Polymerase Chain Reaction (dPCR)6.4 Other Platforms7 Techniques7.1 Overview7.2 Magnetic Beads-Based7.3 Spin Column-Based7.4 Other Techniques8 Application8.1 Overview8.2 Non-Invasive Prenatal Testing (NIPT)8.3 Oncology8.3.1 Solid Tumor8.3.2 Hematological Malignancies8.4 Transplant Rejection8.5 Other Applications9 End User9.1 Overview9.2 Pharmaceutical and Biotechnology Companies9.3 Academic Research Institutes and Laboratories9.4 Contract Research Organizations (CROs)9.5 Clinical Diagnostic Centers9.6 Other End Users10 Region10.1 Overview10.2 North America10.2.1 U.S.10.2.2 Canada10.3 Europe10.3.1 Germany10.3.2 France10.3.3 U.K.10.3.4 Italy10.3.5 Spain10.3.6 Denmark10.3.7 Rest-of-Europe10.4 Asia-Pacific10.4.1 China10.4.2 India10.4.3 Japan10.4.4 South Korea10.4.5 Australia10.4.6 Singapore10.4.7 Rest-of-Asia-Pacific (RoAPAC)10.5 Latin America10.5.1 Brazil10.5.2 Mexico10.5.3 Rest-of-Latin America (RoLA)10.6 Rest-of-the-World11 Company Profiles11.1 Overview11.2 Thermo Fisher Scientific Inc.11.2.1 Company Overview11.2.2 Role of Thermo Fisher Scientific Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.2.3 Financials11.2.4 Key Insights About the Financial Health of the Company11.2.5 SWOT Analysis11.3 QIAGEN11.3.1 Company Overview11.3.2 Role of QIAGEN in the Global Cell-Free DNA Isolation and Extraction Market11.3.3 Financials11.3.4 Key Insights About the Financial Health of the Company11.3.5 SWOT Analysis11.4 Danaher11.4.1 Company Overview11.4.2 Role of Danaher in the Global Cell-Free DNA Isolation and Extraction Market11.4.3 Financials11.4.4 Key Insights About the Financial Health of the Company11.4.5 SWOT Analysis11.5 PerkinElmer, Inc.11.5.1 Company Overview11.5.2 Role of PerkinElmer, Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.5.3 Financials11.5.4 Key Insights About the Financial Health of the Company11.5.5 SWOT Analysis11.6 Endress+Hauser AG11.6.1 Company Overview11.6.2 Role of Endress+Hauser AG in the Global Cell-Free DNA Isolation and Extraction Market11.6.3 Financials11.6.4 Key Insights About the Financial Health of the Company11.6.5 SWOT Analysis11.7 Agilent Technologies, Inc.11.7.1 Company Overview11.7.2 Role of Agilent Technologies, Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.7.3 Financials11.7.4 Key Insights About the Financial Health of the Company11.7.5 SWOT Analysis11.8 F. Hoffmann-La Roche Ltd.11.8.1 Company Overview11.8.2 Role of F. Hoffmann-La Roche Ltd. in the Global Cell-Free DNA Isolation and Extraction Market11.8.3 Financials11.8.4 Key Insights About the Financial Health of the Company11.8.5 SWOT Analysis11.9 Merck KGaA11.9.1 Company Overview11.9.2 Role of Merck KGaA in the Global Cell-Free DNA Isolation and Extraction Market11.9.3 Financials11.9.4 Key Insights About the Financial Health of the Company11.9.5 SWOT Analysis11.1 Illumina, Inc.11.10.1 Company Overview11.10.2 Role of Illumina, Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.10.3 Financials11.10.4 Key Insights About the Financial Health of the Company11.10.5 SWOT Analysis11.11 Takara Bio Inc.11.11.1 Company Overview11.11.2 Role of Takara Bio Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.11.3 Financials11.11.4 Key Insights About the Financial Health of the Company11.11.5 SWOT Analysis11.12 Aline Biosciences11.12.1 Company Overview11.12.2 Role of Aline Biosciences in the Global Cell-Free DNA Isolation and Extraction Market11.12.3 SWOT Analysis11.13 EpiGentek Group, Inc.11.13.1 Company Overview11.13.2 Role of EpiGentek Group, Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.13.3 SWOT Analysis11.14 Omega Bio-tek, Inc.11.14.1 Company Overview11.14.2 Role of Omega Bio-tek, Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.14.3 SWOT Analysis11.15 Promega Corporation11.15.1 Company Overview11.15.2 Role of Promega Corporation in the Global Cell-Free DNA Isolation and Extraction Market11.15.3 SWOT Analysis11.16 Streck, Inc.11.16.1 Company Overview11.16.2 Role of Streck, Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.16.3 SWOT Analysis11.17 AccuBioMed Co., Ltd.11.17.1 Company Overview11.17.2 Role of AccuBioMed Co., Ltd. in the Global Cell-Free DNA Isolation and Extraction Market11.18 AMSBIO11.18.1 Company Overview11.18.2 Role of AMSBIO in the Global Cell-Free DNA Isolation and Purification Market11.19 Covaris, Inc.11.19.1 Role of Covaris, Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.2 EntroGen, Inc.11.20.1 Role of EntroGen, Inc. in the Global Cell-Free DNA Isolation and Extraction Market11.21 NeoGeneStar LLC11.21.1 Company Overview11.21.2 Role of NeoGeneStar LLC in the Global Cell-Free DNA Isolation and Extraction Market11.22 Norgen Biotek Corp.11.22.1 Company Overview11.22.2 Role of Norgen Biotek Corp. in the Global Cell-Free DNA Isolation and Extraction Market11.23 STRATEC SE11.23.1 Company Overview11.23.2 Role of STRATEC SE in the Global Cell-Free DNA Isolation and Extraction Market11.24 System Biosciences, LLC11.24.1 Company Overview11.24.2 Role of System Biosciences, LLC in the Global Cell-Free DNA Isolation and Extraction Market11.25 Vela Diagnostics11.25.1 Company Overview11.25.2 Role of Vela Diagnostics in the Global Cell-Free DNA Isolation and Extraction MarketList of Figures Figure 1: Global Cancer Burden, 2020Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Cell-Free DNA Isolation and Extraction MarketFigure 3: Global Cell-Free DNA Isolation and Extraction Market (by Consumable), $Million, 2020 and 2031Figure 4: Global Cell-Free DNA Isolation and Extraction Market (by Technique), $Million, 2020 and 2031Figure 5: Global Cell-Free DNA Isolation and Extraction Market (by Platform), $Million, 2020 and 2031Figure 6: Global Cell-Free DNA Isolation and Extraction Market (by Application), $Million, 2020 and 2031Figure 7: Global Cell-Free DNA Isolation and Extraction Market (by End User), $Million, 2020 and 2031Figure 8: Global Cell-Free DNA Isolation and Extraction Market SnapshotFigure 9: Global Cell-Free DNA Isolation and Extraction Market: Research MethodologyFigure 10: Primary Research MethodologyFigure 11: Bottom-Up Approach (Segment-Wise Analysis)Figure 12: Top-Down Approach (Segment-Wise Analysis)Figure 13: Global Cell-Free DNA Isolation and Extraction Market SegmentationFigure 14: Global Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 15: Global Cell-Free DNA Isolation and Extraction Market: COVID-19 Impact AnalysisFigure 16: Overview of Regulatory Process for Medical Devices by FDAFigure 17: Overview of Regulatory Process for Medical Devices in EuropeFigure 18: Overview of Regulatory Process for Medical Devices by National Medical Product AdministrationFigure 19: Global Cancer Burden, 2020Figure 20: Share of Key Developments, January 2018-November 2021Figure 21: Share of Product Launch and Upgradations (by Company), January 2018-November 2021Figure 22: Share of Product Approvals and Business Funding (by Company), January 2018-November 2021Figure 23: Share of Synergistic Activities (by Company), January 2018-November 2021Figure 24: Market Share Analysis of Global Cell-Free DNA Isolation and Extraction Market (by Company), 2019 and 2020Figure 25: Growth Share Analysis for Global Cell-Free DNA Isolation and Extraction Market (by Company), 2020Figure 26: Global Cell-Free DNA Isolation and Extraction Market Segmentation (by Consumable)Figure 27: Global Cell-Free DNA Isolation and Extraction Market (by Consumable), $Million, 2020 and 2031Figure 28: Global Cell-Free DNA Isolation and Extraction Market (Cell-Free DNA Isolation and Extraction Kits), $Million, 2020-2031Figure 29: Global Cell-Free DNA Isolation and Extraction Market (Cell-Free DNA Isolation and Extraction Kits), Unit, 2020-2031Figure 30: Global Cell-Free DNA Isolation and Extraction Market (Cell-Free DNA Isolation and Extraction Tubes), $Million, 2020-2031Figure 31: Global Cell-Free DNA Isolation and Extraction Market (Other Consumables), $Million, 2020-2031Figure 32: Global Cell-Free DNA Isolation and Extraction Market Segmentation (by Platform)Figure 33: Global Cell-Free DNA Isolation and Extraction Market (by Platform), $Million, 2020 and 2031Figure 34: Global Cell-Free DNA Isolation and Extraction Market (Next-Generation Sequencing), $Million, 2020-2031Figure 35: Global Cell-Free DNA Isolation and Extraction Market (Next-Generation Sequencing (NGS)), Unit, 2020-2031Figure 36: Global Cell-Free DNA Isolation and Extraction Market (Polymerase Chain Reaction (PCR)), $Million, 2020-2031Figure 37: Global Cell-Free DNA Isolation and Extraction Market (Polymerase Chain Reaction (PCR)), Unit, 2020-2031Figure 38: Global Cell-Free DNA Isolation and Extraction Market (Real-Time Polymerase Chain Reaction (RT-PCR)), $Million, 2020-2031Figure 39: Global Cell-Free DNA Isolation and Extraction Market (Real-Time Polymerase Chain Reaction (RT-PCR)), Unit, 2020-2031Figure 40: Global Cell-Free DNA Isolation and Extraction Market (Digital Polymerase Chain Reaction (dPCR)), $Million, 2020-2031Figure 41: Global Cell-Free DNA Isolation and Extraction Market (Digital Polymerase Chain Reaction (dPCR), Unit, 2020-2031Figure 42: Global Cell-Free DNA Isolation and Extraction Market (Other Platforms), $Million, 2020-2031Figure 43: Global Cell-free DNA Isolation and Extraction Market (Other Platforms), Unit, 2020-2031Figure 44: Global Cell-Free DNA Isolation and Extraction Market (by Technique)Figure 45: Global Cell-Free DNA Isolation and Extraction Market (by Technique), $Million, 2020 and 2031Figure 46: Global Cell-Free DNA Isolation and Extraction Market (Magnetic Beads-Based Technique), $Million, 2020-2031Figure 47: Global Cell-Free DNA Isolation and Extraction Market (Spin Column-Based Technique), $Million, 2020-2031Figure 48: Global Cell-Free DNA Isolation and Extraction Market (Other Techniques), $Million, 2020-2031Figure 49: Global Cell-Free DNA Isolation and Extraction Market (by Application)Figure 50: Global Cell-Free DNA Isolation and Extraction Market (by Application), $Million, 2020 and 2031Figure 51: Global Cell-Free DNA Isolation and Extraction Market (Non-Invasive Prenatal Testing (NIPT)), $Million, 2020-2031Figure 52: Global Cell-Free DNA Isolation and Extraction Market (Non-Invasive Prenatal Testing (NIPT), Unit, 2020-2031Figure 53: Global Cell-Free DNA Isolation and Extraction Market (Oncology), $Million, 2020-2031Figure 54: Global Cell-Free DNA Isolation and Extraction Market (Oncology), Unit, 2020-2031Figure 55: Global Cell-Free DNA Isolation and Extraction Market (Solid Tumor), $Million, 2020-2031Figure 56: Global Cell-Free DNA Isolation and Extraction Market (Hematological Malignancies), $Million, 2020-2031Figure 57: Global Cell-Free DNA Isolation and Extraction Market (Transplant Rejection), $Million, 2020-2031Figure 58: Global Cell-Free DNA Isolation and Extraction Market (Transplant Rejection), Unit, 2020-2031Figure 59: Global Cell-Free DNA Isolation and Extraction Market (Other Applications), $Million, 2020-2031Figure 60: Global Cell-Free DNA Isolation and Extraction Market (Other Applications), Unit, 2020-2031Figure 61: Global Cell-Free DNA Isolation and Extraction Market (by End User)Figure 62: Global Cell-Free DNA Isolation and Extraction Market (by End User), $Million, 2020 and 2031Figure 63: Global Cell-Free DNA Isolation and Extraction Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2031Figure 64: Global Cell-Free DNA Isolation and Extraction Market (Pharmaceutical and Biotechnology Companies), Unit, 2020-2031Figure 65: Global Cell-Free DNA Isolation and Extraction Market (Academic Research Institutes and Laboratories), $Million, 2020-2031Figure 66: Global Cell-Free DNA Isolation and Extraction Market (Academic and Research Institutes and Laboratories), Unit, 2020-2031Figure 67: Global Cell-Free DNA Isolation and Extraction Market (Contract Research Organizations), $Million, 2020-2031Figure 68: Global Cell-Free DNA Isolation and Extraction Market (Contract Research Organizations), Unit, 2020-2031Figure 69: Global Cell-Free DNA Isolation and Extraction Market (Clinical Diagnostics Centers), $Million, 2020-2031Figure 70: Global Cell-Free DNA Isolation and Extraction Market (Clinical Diagnostics Centers), Unit, 2020-2031Figure 71: Global Cell-Free DNA Isolation and Extraction Market (Other End Users), $Million, 2020-2031Figure 72: Global Cell-Free DNA Isolation and Extraction Market (Other End Users), Unit, 2020-2031Figure 73: Global Cell-Free DNA Isolation and Extraction Market Snapshot (by Region), $Million, 2020-2031Figure 74: Global Cell-Free DNA Isolation and Extraction Market (by Region), $Million, 2020-2031Figure 75: Global Cell-Free DNA Isolation and Extraction Market (by Region), $Million, 2020 and 2031Figure 76: North America Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 77: North America: Market DynamicsFigure 78: North America Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031Figure 79: North America Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031Figure 80: U.S. Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 81: U.S. Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 82: U.S. Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031Figure 83: Canada Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 84: Canada Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 85: Canada Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031Figure 86: Europe Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 87: Europe: Market DynamicsFigure 88: Europe Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031Figure 89: Europe Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 90: Europe Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031Figure 91: Germany Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 92: Germany Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 93: Germany Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031Figure 94: France Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 95: France Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 96: France Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031Figure 97: U.K. Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 98: U.K. Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 99: U.K. Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031Figure 100: Italy Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 101: Italy Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 102: Italy Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031Figure 103: Spain Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 104: Spain Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 105: Spain Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031Figure 106: Denmark Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 107: Denmark Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 108: Denmark Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031Figure 109: Rest-of-Europe Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 110: Rest-of-Europe Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031Figure 111: Rest-of-Europe Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031Figure 112: Asia-Pacific Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 113: Asia-Pacific: Market DynamicsFigure 114: APAC Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031Figure 115: China Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 116: India Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 117: Japan Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 118: South Korea Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 119: Australia Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 120: Singapore Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 121: RoAPAC Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 122: Latin America Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 123: Latin America: Market DynamicsFigure 124: Latin America Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031Figure 125: Brazil Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 126: Mexico Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 127: Rest-of-Latin America (RoLA) Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 128: Rest-of-the-World (RoW) Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031Figure 129: Total Number of Companies ProfiledFigure 130: Thermo Fisher Scientific Inc.: Product PortfolioFigure 131: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020Figure 132: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2018-2020Figure 133: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018-2020Figure 134: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020Figure 135: Thermo Fisher Scientific Inc.: SWOT AnalysisFigure 136: QIAGEN: Product PortfolioFigure 137: QIAGEN: Overall Financials, $Million, 2018-2020Figure 138: QIAGEN N.V.: Revenue (by Segment), $Million, 2018-2020Figure 139: QIAGEN N.V.: Revenue (by Region), $Million, 2018-2020Figure 140: QIAGEN N.V.: R&D Expenditure, $Million, 2018-2020Figure 141: QIAGEN N.V.: SWOT AnalysisFigure 142: Danaher: Product PortfolioFigure 143: Danaher Corporation: Overall Financials, $Million, 2018-2020Figure 144: Danaher: Revenue (by Segment), $Million, 2018-2020Figure 145: Danaher: Revenue (by Region), $Million, 2018-2020Figure 146: Danaher: R&D Expenditure, $Million, 2018-2020Figure 147: Danaher: SWOT AnalysisFigure 148: PerkinElmer, Inc.: Product PortfolioFigure 149: PerkinElmer, Inc.: Overall Financials, $Million, 2018-2020Figure 150: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2018-2020Figure 151: PerkinElmer, Inc.: Revenue (by Region), $Million, 2018-2020Figure 152: PerkinElmer, Inc.: R&D Expenditure, $Million, 2018-2020Figure 153: PerkinElmer, Inc.: SWOT AnalysisFigure 154: Endress+Hauser AG: Product PortfolioFigure 155: Endress+Hauser AG: Overall Financials, $Million, 2018-2020Figure 156: Endress+Hauser AG: Revenue (by Segment), $Million, 2018-2020Figure 157: Endress+Hauser AG: Revenue (by Region), $Million, 2018-2020Figure 158: Endress+Hauser AG: R&D Expenditure, $Million, 2018-2020Figure 159: Endress+Hauser AG: SWOT AnalysisFigure 160: Agilent Technologies, Inc.: Product PortfolioFigure 161: Agilent Technologies, Inc.: Overall Financials, $Million, 2018-2020Figure 162: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2018-2020Figure 163: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2018-2020Figure 164: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2018-2020Figure 165: Agilent Technologies, Inc.: SWOT AnalysisFigure 166: F. Hoffmann-La Roche Ltd.: Product PortfolioFigure 167: F. Hoffmann-La Roche Ltd.: Overall Financials, $Million, 2018-2020Figure 168: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2018-2020Figure 169: F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2018-2020Figure 170: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2018-2020Figure 171: F. Hoffmann-La Roche Ltd.: SWOT AnalysisFigure 172: Merck KGaA: Product PortfolioFigure 173: Merck KGaA: Overall Financials, $Million, 2018-2020Figure 174: Merck KGaA: Revenue (by Segment), $Million, 2018-2020Figure 175: Merck KGaA: Revenue (by Region), $Million, 2018-2020Figure 176: Merck KGaA: R&D Expenditure, $Million, 2018-2020Figure 177: Merck KGaA: SWOT AnalysisFigure 178: Illumina, Inc.: Product PortfolioFigure 179: Illumina, Inc.: Overall Financials, $Million, 2018-2020Figure 180: Illumina, Inc.: Revenue (by Segment), $Million, 2018-2020Figure 181: Illumina, Inc.: Revenue (by Region), $Million, 2018-2020Figure 182: Illumina, Inc.: R&D Expenditure, $Million, 2018-2020Figure 183: Illumina, Inc.: SWOT AnalysisFigure 184: Takara Bio Inc.: Product PortfolioFigure 185: Takara Bio Inc.: Overall Financials, $Million, 2018-2020Figure 186: Takara Bio Inc.: Revenue (by Segment), $Million, 2018-2020Figure 187: Takara Bio Inc.: Revenue (by Region), $Million, 2018-2020Figure 188: Takara Bio Inc.: R&D Expenditure, $Million, 2018-2021Figure 189: Takara Bio Inc.: SWOT AnalysisFigure 190: Aline Biosciences: Product PortfolioFigure 191: Aline Biosciences: SWOT AnalysisFigure 192: EpiGentek Group, Inc.: Product PortfolioFigure 193: EpiGentek Group, Inc.: SWOT AnalysisFigure 194: Omega Bio-tek, Inc.: Product PortfolioFigure 195: Omega Bio-tek, Inc.: SWOT AnalysisFigure 196: Promega Corporation: Product PortfolioFigure 197: Promega Corporation: SWOT AnalysisFigure 198: Streck, Inc.: Product PortfolioFigure 199: Streck, Inc.: SWOT AnalysisFigure 200: AccuBioMed Co., Ltd.: Product PortfolioFigure 201: AMSBIO: Product PortfolioFigure 202: Covaris, Inc.: Product PortfolioFigure 203: EntroGen, Inc.: Product PortfolioFigure 204: NeoGeneStar LLC: Product PortfolioFigure 205: Norgen Biotek Corp.: Product PortfolioFigure 206: STRATEC SE: Product PortfolioFigure 207: System Biosciences, LLC: Product PortfolioFigure 208: Vela Diagnostics: Product PortfolioList of Tables Table 1: Classification of Medical DeviceTable 2: Likert ScaleTable 3: Impact Analysis of Market DriversTable 4: Impact Analysis of Market RestraintsTable 5: Cell-Free DNA Isolation and Extraction Tubes Offered by Key Market PlayersTable 6: List of Kits Using Spin Column-Based Technique